Why Your Cardiac Surgery Risk Score Matters More Than You Think
When a surgeon tells you that you need heart surgery, one of the first things that should happen is a formal risk assessment. This is not a guess. It is a calculation based on your specific clinical data — your age, kidney function, heart muscle strength, the type of operation planned, and a dozen other variables — fed into a validated scoring system that estimates your likelihood of complications or death.
Two systems dominate the world of cardiac surgery risk prediction: the STS (Society of Thoracic Surgeons) risk score, used primarily in North America, and the EuroSCORE II calculator, the standard across much of Europe and large parts of Asia, Africa, and South America. If you have been quoted a risk number and are not sure which system was used, or if you are comparing opinions from surgeons in different countries, this article will help you make sense of what you are looking at.
As a board-certified cardiovascular and thoracic surgeon, I use both systems regularly. They are not interchangeable, and understanding their differences can directly affect the decisions you and your family make about your care.
What Is the EuroSCORE II Calculator and How Does It Work?
The original EuroSCORE (European System for Cardiac Operative Risk Evaluation) was introduced in 1999 based on data from nearly 20,000 patients across 128 European centers. It was a significant step forward — for the first time, surgeons had a standardized tool to estimate operative mortality for cardiac surgery patients across Europe.
However, cardiac surgery improved dramatically over the following decade. Mortality rates dropped, techniques evolved, and the original EuroSCORE began to overestimate risk, sometimes significantly. A patient who the original model predicted had a 10% risk of death might, in contemporary practice, have a true risk closer to 3-4%. This overestimation was a real problem — it could push patients toward less effective treatments or away from surgery altogether.
The EuroSCORE II was released in 2012 to correct this. Built on data from over 22,000 patients at 154 hospitals across 43 countries, it uses 18 variables to produce a more accurate estimate of 30-day operative mortality. These variables include:
- Age and sex
- Kidney function (creatinine clearance)
- Presence of chronic lung disease, diabetes, or peripheral artery disease
- Left ventricular function (how well your heart pumps)
- Whether this is a redo operation
- The urgency of surgery (elective, urgent, emergent, or salvage)
- The specific procedure being performed
- Active endocarditis, critical preoperative state, and other acute factors
When your surgeon or cardiologist uses the European cardiac surgery risk score, they enter these data points into a calculator — typically an online tool or integrated software — and receive a percentage representing your estimated risk of dying within 30 days of surgery. A score of 2% means that, among 100 patients with your profile, approximately two would be expected not to survive the first month after the operation.
EuroSCORE vs STS: Key Differences Patients Should Understand
Both the EuroSCORE II and the STS risk score aim to do the same thing: give surgeons and patients an honest, data-driven estimate of surgical risk. But they do it differently, and the numbers they produce are not directly comparable. Here is what matters most to you as a patient.
Different Databases, Different Populations
The STS score is built on a continuously updated database of millions of North American cardiac surgery cases. The EuroSCORE II was derived from a multinational European dataset collected during a specific time window (2010). This means the STS score reflects ongoing, real-time outcomes from U.S. and Canadian centers, while the EuroSCORE II reflects a snapshot of European practice from over a decade ago.
In practical terms, this means the STS score may be more current for North American patients, while the EuroSCORE II may be more relevant for patients treated in European or international centers — though neither is perfect for any individual.
What They Predict
The STS score provides multiple outcome predictions: operative mortality, stroke, renal failure, prolonged ventilation, deep sternal wound infection, reoperation, and a composite morbidity/mortality endpoint. It gives a broader picture of what could go wrong.
The EuroSCORE II, by contrast, predicts primarily operative mortality. It does not estimate your risk of stroke, kidney failure, or prolonged ICU stay. This is a meaningful limitation. Two patients might have similar mortality estimates but very different risks of a disabling stroke — and the EuroSCORE II alone will not tell you that.
Accuracy and Known Limitations
Multiple validation studies have shown that EuroSCORE II performs reasonably well for moderate-risk patients but can lose accuracy at the extremes. Several studies, including a 2014 analysis published in the European Journal of Cardio-Thoracic Surgery, have shown that EuroSCORE II tends to overestimate risk in low-risk patients and may underestimate risk in very high-risk patients. The STS score has its own calibration challenges, but its continuous database updates help it stay closer to real-world outcomes over time.
For patients considering transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR), this distinction is especially important. Many of the landmark TAVR trials used the STS score to classify patients as low, intermediate, or high risk. If your team quoted you a EuroSCORE II number to justify a TAVR recommendation, it is worth asking how that translates to an STS equivalent — because the thresholds are not the same. You can explore this further with our free cardiac surgery risk calculator.
A Side-by-Side Summary
- STS Score: Continuously updated, North American data, predicts mortality and major complications, procedure-specific models for CABG, valve, and combined operations.
- EuroSCORE II: Based on 2010 European data, predicts mortality only, covers a broader range of cardiac procedures including aortic surgery and miscellaneous operations, widely used internationally.
When the European Cardiac Surgery Risk Score Influences Your Treatment Decision
Risk scores are not just academic exercises. They directly influence whether you are offered surgery, what type of procedure is recommended, and whether you might be considered too high-risk for conventional operation.
Here are real scenarios where the EuroSCORE II calculator comes into play:
TAVR vs. SAVR decisions: European guidelines from the ESC/EACTS use EuroSCORE II as one factor in determining whether a patient with aortic stenosis should undergo TAVR or open surgical valve replacement. A EuroSCORE II above 4% generally tips the recommendation toward TAVR in older patients, while lower scores may favor surgery — though age, anatomy, and frailty also matter enormously. If you are facing this decision, understanding your specific score and its context is critical.
High-risk surgical candidacy: If your EuroSCORE II is above 8-10%, your surgical team may begin discussing whether the expected benefit of surgery outweighs the estimated risk. In some cases, palliative or medical management may be recommended instead. But these are the exact situations where the score's accuracy matters most — and where it is most likely to be imprecise.
International second opinions: If you received a risk assessment from a surgeon in Europe or Asia using EuroSCORE II, and you are now seeking a second opinion from a North American surgeon who uses the STS score, the numbers will not match. This does not mean one surgeon is wrong. It means they are using different measuring tools. A thorough cardiac surgery second opinion will recalculate your risk using the appropriate model and interpret it in the context of your full clinical picture.
What a Risk Score Cannot Tell You
No risk calculator — EuroSCORE II, STS, or otherwise — captures everything that matters. These models do not account for:
- Frailty: A 78-year-old who walks two miles daily and a 78-year-old who cannot get out of a chair unassisted may generate identical scores, but their real-world outcomes will differ dramatically.
- Surgeon and hospital volume: The skill and experience of your specific surgeon, and the volume of your hospital, are among the strongest predictors of outcome in cardiac surgery. Risk calculators assume an "average" surgical environment.
- Anatomic complexity: A heavily calcified or porcelain aorta, unusual coronary anatomy, or prior chest radiation can make an operation far more dangerous than any score suggests.
- Patient goals and values: A risk score tells you the probability of dying. It does not tell you whether the trade-off is worth it for your life, your family, and your priorities.
This is precisely why I believe a risk score should start a conversation, not end one. When a number is used in isolation to make a surgical recommendation — especially a number from a model that may not be optimally calibrated for your specific situation — you owe it to yourself to ask questions.
How to Use Your Risk Score Wisely
If you have been given a EuroSCORE II result, here are practical steps I recommend:
- Ask which score was used and why. If you are a North American patient and your surgeon used EuroSCORE II instead of the STS score, ask the reasoning. Both are valid, but the context matters.
- Request the STS score as well. For major decisions — particularly TAVR vs. SAVR or high-risk CABG — having both scores gives a more complete picture. Our risk calculator can help you understand these numbers.
- Understand what the score does and does not predict. If you were told your EuroSCORE II mortality risk is 5%, ask about your risk of stroke, kidney injury, and prolonged recovery. These may matter more to you than the mortality number alone.
- Consider the source of the data. EuroSCORE II was calibrated on data from 2010. Surgical outcomes have improved since then, particularly at high-volume centers. Your actual risk at an experienced center may be lower than the calculator suggests.
- Get an independent interpretation. A second set of expert eyes reviewing your imaging, catheterization data, and clinical history — not just re-running a calculator — can reveal whether the recommended approach is truly the best one for you.
The Bottom Line on EuroSCORE vs STS for Patients
Both the EuroSCORE II and the STS risk score are valuable tools. Neither is perfect. The EuroSCORE II is a well-validated European cardiac surgery risk score that serves as the international standard outside North America, but it predicts only mortality, is based on older data, and can lose precision at the extremes of risk. The STS score offers more granular predictions and benefits from a continuously updated database, but it is calibrated primarily for North American populations.
What matters most is not which calculator was used but whether your surgical team interpreted the result thoughtfully, accounted for factors the model cannot capture, and involved you in a shared decision based on the full picture of your health.
If you have been given a surgical recommendation based on a risk score you do not fully understand — or if the numbers from different surgeons do not seem to agree — a WhiteGloveMD second opinion can help. We review your complete medical record, recalculate your risk using the most appropriate models, and provide a clear, independent surgical recommendation written by a board-certified cardiac surgeon. No jargon. No upsell. Just the information you need to make the best decision for your heart and your life.
If you are facing a cardiac surgery decision and want to understand what your risk score truly means for you, start a WhiteGloveMD review today.